- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
- Complementary Medicine (alternative medicine) not so good for cancer patients
- Patient Problem Based Learning – new approach to medical classes
- Hematopoietic stem cell transplantation in Multiple Sclerosis – effective 1st, 2nd and 3rd line treatment